Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Isabel Kurth

Showing results (11-20 of 17) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 17 results.
Blood|May 17, 2003
Ex vivo characterization of human CD8+ T subsets with distinct replicative history and partial effector functionsNathalie Rufer, Alfred Zippelius, Pascal Batard, et al.
Journal of Experimental & Clinical Cancer Research : CR|March 28, 2026
RGX-019-MMAE inhibits leukemia progression by targeting MER proto-oncogene tyrosine kinase (MERTK) in acute myeloid leukemiaAnudishi Tyagi, Maryam Siddiqui, Amanda Eckstrom, et al.
Cancer Research|February 9, 2026
A MERTK-Targeting Antibody-Drug Conjugate Selectively Depletes M2 Tumor-Associated Macrophages and MERTK-Expressing Cancer CellsShugaku Takeda, Subhasree Sridhar, Daniel Schefer, et al.
Journal of Medicinal Chemistry|February 6, 2026
Carboxylic Acid Bioisosteres of Creatine as Novel and Selective Substrate Competitive Inhibitors of the Creatine Transporter SLC6A8Eduardo J Martinez, Darren H Wong, Amish J Patel, et al.
Cell|January 17, 2018
LXR/ApoE Activation Restricts Innate Immune Suppression in CancerMasoud F Tavazoie, Ilana Pollack, Raissa Tanqueco, et al.
Biorxiv : the Preprint Server for Biology|September 18, 2025
Tumor Genotype Dictates Mitochondrial and Immune Vulnerabilities in Liver CancerGokhan Unlu, Alon Millet, Khando Wangdu, et al.
Science Advances|October 6, 2021
Therapeutic targeting of SLC6A8 creatine transporter suppresses colon cancer progression and modulates human creatine levelsIsabel Kurth, Norihiro Yamaguchi, Celia Andreu-Agullo, et al.
Pageof 2

Showing results (11-20 of 17) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 17 results.
Blood|May 17, 2003
Ex vivo characterization of human CD8+ T subsets with distinct replicative history and partial effector functionsNathalie Rufer, Alfred Zippelius, Pascal Batard, et al.
Journal of Experimental & Clinical Cancer Research : CR|March 28, 2026
RGX-019-MMAE inhibits leukemia progression by targeting MER proto-oncogene tyrosine kinase (MERTK) in acute myeloid leukemiaAnudishi Tyagi, Maryam Siddiqui, Amanda Eckstrom, et al.
Cancer Research|February 9, 2026
A MERTK-Targeting Antibody-Drug Conjugate Selectively Depletes M2 Tumor-Associated Macrophages and MERTK-Expressing Cancer CellsShugaku Takeda, Subhasree Sridhar, Daniel Schefer, et al.
Journal of Medicinal Chemistry|February 6, 2026
Carboxylic Acid Bioisosteres of Creatine as Novel and Selective Substrate Competitive Inhibitors of the Creatine Transporter SLC6A8Eduardo J Martinez, Darren H Wong, Amish J Patel, et al.
Cell|January 17, 2018
LXR/ApoE Activation Restricts Innate Immune Suppression in CancerMasoud F Tavazoie, Ilana Pollack, Raissa Tanqueco, et al.
Biorxiv : the Preprint Server for Biology|September 18, 2025
Tumor Genotype Dictates Mitochondrial and Immune Vulnerabilities in Liver CancerGokhan Unlu, Alon Millet, Khando Wangdu, et al.
Science Advances|October 6, 2021
Therapeutic targeting of SLC6A8 creatine transporter suppresses colon cancer progression and modulates human creatine levelsIsabel Kurth, Norihiro Yamaguchi, Celia Andreu-Agullo, et al.
Pageof 2